Major players in the global food and beverage industry are apprehensively waiting for the World Health Organization's (WHO) impending declaration of aspartame as a possible carcinogen. This widely-used artificial sweetener is a key ingredient in numerous diet drinks, yogurt drinks, and sugar-free gums.
The Korea Times reported that in South Korea, officials said on Sunday, June 2, that the International Agency for Research on Cancer (IARC), which is operating under WHO, is set to classify the said sweetener as "possibly carcinogenic to humans."
It was mentioned that aspartame is one of the most popular substitutes to sweeten foods and beverages without adding sugar. It is commonly used in Diet Coke, Diet Snapple, yogurt drinks, chewing gums, and makgeolli in South Korea.
Moreover, in the local market, Pepsi Zero, which Lotte Chilsung Beverage is distributing, also has aspartame as an ingredient. The company has been importing this soda drink directly from PepsiCo's main office in New York and only bottles them in Korea.
"Aspartame has been used by F&B companies around the world for a long time. It is not an issue of an individual company but rather that of the whole related industry, globally. We are currently discussing the matter with the Ministry of Food and Drug Safety (MFDS) and will wait to see what they have to say," an official at Lotte Chilsung Beverage said in a statement.
If aspartame is classified as a carcinogen, Lotte will suffer great economic damage since sales of Pepsi Zero is likely to drop with the news. Fortune reported that WHO is set to officially announce the results of its evaluations starting on July 14.
Finally, WHO initially said that there is still limited evidence that links aspartame to cancer, and it is the lowest of three categories which are "probable carcinogen" and "carcinogenic to humans."
Photo by: Alexander Grey/Unsplash


Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal
KOSPI Eyes Best Weekly Gain Since June as Samsung, SK Hynix Rally
Gold Prices Slip From Two-Month High as Inflation and Fed Outlook Drive Markets
European Stocks Rise as U.S. Inflation Data Eases Fed Rate Hike Fears
Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook
European Stocks Steady as U.S.-Iran War, Euro Zone Data Keep Investors Cautious
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
Bill Ackman’s Pershing Square Returns to Netflix With Major New Stake
UK Economy Posts Surprise June Growth as World Cup and Hot Weather Lift Activity
US Dollar Holds Firm as Fed Outlook and Iran Tensions Keep Markets on Edge
LG, Nvidia Expand AI Partnership With Humanoid Robots, AI Factories
Wall Street Hits Record High as Softer Inflation Data Eases Fed Rate Hike Fears
Bank of America to Buy Up to 49.9% Stake in Jio Credit for $1.92 Billion
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy
KOSPI Rebounds 20% as Samsung, SK Hynix Lead South Korea Stock Rally 



